Resources
The AMA has collected more than 400 educational and other resources to provide evidence-based recommendations for physicians and policymakers.
The AMA has collected more than 400 educational and other resources to provide evidence-based recommendations for physicians and policymakers.
This issue brief seeks to dispel myths and provide practical strategies to save lives and reduce harms from drug-related overdose.
Added 11/8/23
An infographic showing how the September 22, 2022 US Food and Drug Administration (FDA) Guidance operates to remove barriers to access for harm reduction programs. Special thanks to: Alliance For The People, Remedy, and Nabarun Dasgupta. Infographic On 2022 Fda Naloxone Distribution Guidance. 2022. https://doi.org/10.17615/xhfz-6m65
From 2016 to 2021, naloxone prescriptions dispensed from pharmacies increased from almost 134,000 to nearly 1.2 million prescriptions.
Updated August 2017
Surgeon General of the United States Public Health Service, VADM Jerome Adams, MD
Prescribe to Prevent
The AMA Substance Use and Pain Care Task Force urges physicians and other health care professions to continue taking action to help reverse the nation’s drug overdose epidemic—and the Task Force also calls on policymakers to take specific steps to remove barriers to evidence-based care for patients with pain and those with a substance use disorder.
Learn More Join the AMA today and help us lead the effort
to reverse the nation’s opioid epidemic.